The Symphony of Survival: Sacubitril/Valsartan’s Heartfelt Impact on Mortality in Heart Failure: A Systemic Review

Abstract

Heart failure (HF) is a prevalent and debilitatingcondition affecting millions worldwide. Over the years,numerous therapeutic strategies have been employedto manage HF, improving patients' quality of life, andreducing morbidity and mortality rates.Sacubitril/valsartan, a novel combination drug, hasemerged as a promising therapeutic option in themanagement of HF with reduced ejection fraction(HFrEF This abstract provides a comprehensive reviewof the use of sacubitril/valsartan in treating HF patients.